Involvement of neuronal Nitric oxide synthase in desensitisation of μ-opioid receptors in the rat locus coeruleus

Journal of Psychopharmacology

Volumn 28, Issue 10, 2014, Pages 903-914

  Santamarta, María T ^a   Llorente, Javier ^a   Mendiguren, Aitziber ^a   Pineda, Joseba ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Brain slices; Desensitisation; Electrophysiology; Locus coeruleus; Nitric oxide; Noradrenaline; Opiates

Indexed keywords

7-NITROINDAZOLE; ARGININE; CITRULLINE; FERRICYANIDE; INDAZOLE DERIVATIVE; METENKEPHALIN; MU OPIATE RECEPTOR; N(G)-IMINOETHYLORNITHINE; N(OMEGA)-PROPYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; NORADRENALIN; ORNITHINE; POTASSIUM FERRICYANIDE; S-METHYLTHIOCITRULLINE; THIOUREA;

ACTION POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; DRUG EFFECTS; LOCUS CERULEUS; MALE; NERVE CELL INHIBITION; PHYSIOLOGY; RAT;

ACTION POTENTIALS; ANIMALS; ARGININE; CITRULLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, METHIONINE; FERRICYANIDES; INDAZOLES; LOCUS COERULEUS; MALE; NEURAL INHIBITION; NITRIC OXIDE SYNTHASE TYPE I; NITROPRUSSIDE; NOREPINEPHRINE; ORNITHINE; RATS; RECEPTORS, OPIOID, MU; THIOUREA;

EID: 84907520394     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881114538542     Document Type: Article

References (61)

1. Aghajanian GK and Wang YY (1987) Common alpha 2- and opiate effector mechanisms in the locus coeruleus: Intracellular studies in brain slices. Neuropharmacology 26:793-799.
2. Alderton WK, Cooper CE and Knowles RG (2001) Nitric oxide synthases: Structure, function and inhibition. Biochem J 357:593-615.
3. Alvarez VA, Arttamangkul S, Dang V, et al. (2002) Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 22:5769-5776.
4. Arttamangkul S, Lau EK, Lu H-W, et al. (2012) Desensitization and trafficking of μ-opioid receptors in locus ceruleus neurons: Modulation by kinases. Mol Pharmacol 81:348-355.
5. Arttamangkul S, Quillinan N, Low MJ, et al. (2008) Differential activation and trafficking of μ-opioid receptors in brain slices. Mol Pharmacol 74:972-979.
6. Ayajiki K, Fujioka H, Okamura T, et al. (2001) Relatively selective neuronal nitric oxide synthase inhibition by 7-nitroindazole in monkey isolated cerebral arteries. Eur J Pharmacol 423:179-183.
7. Babbedge RC, Bland-Ward PA, Hart SL, et al. (1993) Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol 110:225-228.
8. Babu BR, Frey C and Griffith OW (1999) L-Arginine binding to nitricoxide synthase: The role of H-bonds to the nonreactive guanidinium nitrogens. J Biol Chem 274:25218-25226.
9. Bailey CP, Oldfield S, Llorente J, et al. (2009) Involvement of PKCa and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of μ-opioid receptors in mature brain neurons. Br J Pharmacol 158:157-164.
10. Bhargava HN, Bian J.-T and Kumar S (1997) Mechanism of attenuation of morphine antinociception by chronic treatment with L-arginine. J Pharmacol Exp Ther 281:707-712.
11. Blanchet C, Sollini M and Lüscher C (2003) Two distinct forms of desensitization of G-protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide-opioid receptor agonists. Mol Cell Neurosci 24:517-523.
12. Bredt DS, Hwang PM and Snyder SH (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770.
13. Chaillet P, Marçais-Collado H, Costentin J, et al. (1983) Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor. Eur J Pharmacol 86:329-336.
14. Cooper GR, Mialkowski K and Wolff DJ (2000) Cellular and enzymatic studies of N-propyl-L-arginine and S-ethyl-N-[4-(trifluoromethyl) phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform. Arch Biochem Biophys 375:183-194.
15. Cuéllar B, Fernández AP, Lizasoain I, et al. (2000) Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacology 148:66-73.
16. Daff S (2010) NO synthase: Structures and mechanisms. Nitr Ox Biol Chem 23:1-11.
17. Dang VC and Christie MJ (2012) Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. Br J Pharmacol 165:1704-1716.
18. Furfine ES, Harmon MF, Paith JE, et al. (1994) Potent and selective inhibition of human nitric oxide synthases: Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and s-ethyl-L-thiocitrulline. J Biol Chem 269:26677-26683
19. Handy R LC and Moore PK (1998) Handy and Moore reply: 7-nitroindazole (7-NI) fails to increase blood pressure in animals: The 7-NI 'conundrum'. Trends Pharmacol Sci 19:350.
20. Harris GC and Williams JT (1991) Transient homologous μ-opioid receptor desensitization in rat locus coeruleus neurons. J Neurosci 11:2574-2581.
21. Heinzen EL and Pollack GM (2004a) Pharmacodynamics of morphineinduced neuronal nitric oxide production and antinociceptive tolerance development. Brain Res 1023:175-184.
22. Heinzen EL and Pollack GM (2004b) The development of morphine antinociceptive tolerance in nitric oxide synthase-deficient mice. Biochem Pharmacol 67:735-741.
23. Hess DT, Lin LH, Freeman JA, et al. (1994) Modification of cysteine residues within G (o) and other neuronal proteins by exposure to nitric oxide. Neuropharmacology 33:1283-1292.
24. Highfield D, A and Grant S (1998) N-nitro-L-arginine, an NOS inhibitor, reduces tolerance to morphine in the rat locus coeruleus. Synapse 29:233-239.
25. Ichihara A, Inscho EW, Imig JI, et al. (1998) Neuronal nitric oxide synthase modulates rat renal microvascular function. Am J Physiol 274:F516-F524.
26. Izumi Y, Benz AM, Clifford DB, et al. (1996) Nitric oxide inhibitors attenuate ischemic degeneration in the CA1 region of rat hippocampal slices. Neurosci Lett 210:157-160.
27. Javelle N, Bérod A, Renaud B, et al. (2002) NO synthase inhibitors attenuate locus coeruleus catecholamine metabolism and behaviour induced by morphine withdrawal. Neuroreport 13:725-728.
28. Kimes AS, Vaupel DB and London ED (1993) Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology 112:521-524.
29. Kolesnikov YA, Pick CG, Cisewska G, et al. (1993) Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc Nat Acad Sci U. S. A 90:5162-5166.
30. Liu JG and Anand K JS (2001) Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Rev 38:1-19.
31. Llorente J, Lowe JD, Sanderson HS, et al. (2012b) μ-Opioid receptor desensitization: Homologous or heterologous? Eur J Neurosci 36:3636-3642.
32. Llorente J, Santamarta MT, Henderson G and Pineda J (2012a) Enhancement of μ opioid receptor desensitization by nitric oxide in rat locus coeruleus neurons: Involvement of reactive oxygen species. J Pharmacol Exp Ther 342:552-560.
33. Lue WM, Su MT, Lin WB, et al. (1999) The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices. Eur J Pharmacol 383:129-135.
34. Machelska H, Ziólkowska B, Mika J, et al. (1997) Chronic morphine increases biosynthesis of nitric oxide synthase in the rat spinal cord. Neuroreport 8:2743-2747.
35. Morgan MM and Christie MC (2011) Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br J Pharmacol 164:1322-1334.
36. Nagi K and Piñeyro G (2011) Regulation of opioid receptor signalling: Implications for the development of analgesic tolerance. Mol Brain 4:25-33.
37. Patey G, De La Baume S and Schwatz JC (1981) Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition. Science 212:1153-1155.
38. Paxinos G and Watson C (2005) The Rat Brain in Stereotaxic Coordinates. 5th ed, Burlington, Massachusetts: Elsevier Academic Press.
39. Pfeifer A, Nurnberg B, Kamm S, et al. (1995) Cyclic GMP-dependent protein kinase blocks pertussis toxin-sensitive hormone receptor signaling pathways in Chinese hamster ovary cells. J Biol Chem 270:9052-9059.
40. Pineda J, Kogan JH and Aghajanian GK (1996) Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: Involvement of a nonselective cationic channel. J Neurosci 16:1389-1399.
41. Pineda J, Torrecilla M, Martín-Ruiz R, et al. (1998) Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats. Neuropharmacology 37:759-767.
42. Rees DD, Palmer RM, Schulz R, et al. (1990) Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101:746-752.
43. Roques BP (2000) Novel approaches to targeting neuropeptide systems. Trends Pharmacol Sci 21:475-483.
44. Ruiz-Durántez E, Llorente J, Ulibarri I, et al. (2003) Agmatinemorphine interaction on nociception in mice. Ann NY Acad Sci 1009:133-135.
45. Santamarta MT, Ulibarri I and Pineda J (2005) Inhibition of neuronal nitric oxide synthase attenuates the development of morphine tolerance in rats. Synapse 57:38-46.
46. Schuman EM, Meffert MK, Schulman H, et al. (1994) An ADP-ribosyltransferase as a potential target for nitric oxide action in hippocampal long-term potentiation. Proc Nat Acad Sci U. S. A 91:11958-11962.
47. Sim-Selley LJ, Selley DE, Vogt LJ, et al. (2000) Chronic heroin self-administration desensitizes μ opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci 20:4555-4562.
48. Simaan J and Sabra R (2011) In-vivo evidence of a role for nitric oxide in regulating the activity of the norepinephrine transporter. Eur J Pharmacol 671:102-106.
49. Song B and Marvizón J CG (2003) Peptidases prevent μ-opioid receptor internalization in dorsal horn neurons by endogenously released opioids. J Neurosci 23:1847-1858.
50. Terwilliger RZ, Ortiz J, Guitart X, et al. (1994) Chronic morphine administration increases beta-adrenergic receptor kinase (beta ARK) levels in the rat locus coeruleus. J Neurochem 63:1983-1986.
51. Torrecilla M, Pineda J and Ugedo L (2001) NO synthase inhibitors reduce opioid desensitization in rat locus coeruleus neurons in vitro. Neuroreport 12:1601-1604.
52. Torrecilla M, Ruiz-Ortega JA, Ugedo L, et al. (2007) Excitatory regulation of noradrenergic neurons by L-arginine/nitric oxide pathway in the rat locus coeruleus in vivo. Naunyn Schmiedeberg's Arch Pharmacol 375:337-347.
53. Uzbay IT and Oglesby MW (2001) Nitric oxide and substance dependence. Neurosci Biobehav Rev 25:43-52.
54. Vaupel DB, Kimes AS and London ED (1997) Further in vivo studies on attenuating morphine withdrawal: Isoform selective nitric oxide synthase inhibitors differ in efficacy. Eur J Pharmacol 324:11-20.
55. Von Zastrow M (2010) Regulation of opioid receptors by endocytic membrane traffic: Mechanisms and translational implications. Drug Alcohol Depend 108:166-171.
56. Waldhoer M, Bartlett SE and Whistler JL (2004) Opioid receptors. Ann Rev Biochem 73:953-990.
57. Williams JT and North RA (1984) Opiate-receptor interactions on single locus coeruleus neurons. Mol Pharmacol 26:489-497
58. Williams JT, Christie MJ and North RA (1987) Potentiation of enkephalin action by peptidase inhibitors in rat locus coeruleus in vitro. J Pharmacol Exp Ther 243:397-401.
59. Williams JT, Ingram SL, Henderson G, et al. (2013) Regulation of μ-opioid receptors: Desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev 65:223-254.
60. Xu ZQ, De Vente J, Steinbusch H, et al. (1998) The NO-cGMP pathway in the rat locus coeruleus: Electrophysiological, immunohistochemical and in situ hybridization studies. Eur J Neurosci 10:3508-3516.
61. Zhang HQ, Fast W, Marletta MA, et al. (1997) Potent and selective inhibition of neuronal nitric oxide synthase by N-propyl-L-arginine. J Med Chem 40:3869-3870.